Japan approves new Novo Nordisk hemophilia drug - will launch in 2024
The hemophilia A and B candidate concizumab is on its way to Japanese shelves.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.